World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
76
Citations
16570
World Ranking
1939
National Ranking
134

Hinrich Abken publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Hinrich Abken sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 266 publications — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Hinrich Abken D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Hinrich Abken sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 76 D-Index — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Hinrich Abken is affiliated with the University of Regensburg in Germany. Their research focuses primarily on fields related to medicine, immunology and microbiology, and biochemistry, genetics, and molecular biology. The scientist has a significant publication record in oncology, immunology, molecular biology, genetics, and biomedical engineering as main subfields of study.

The core topics of Abken's research include:

  • CAR-T cell therapy research
  • Immune cell function and interaction
  • Viral infectious diseases and gene expression in insects
  • Virus-based gene therapy research
  • Immunotherapy and immune responses
  • Nanowire synthesis and applications
  • T-cell and B-cell immunology

Frequent co-authors collaborating with Hinrich Abken include:

  • Markus Barden
  • Astrid Holzinger
  • Axel Schambach
  • Claudia Rössig
  • Andreas Hombach

Abken has published multiple papers in journals and venues where they have contributed repeatedly, among them:

  • Frontiers in Immunology
  • Cells
  • Journal for ImmunoTherapy of Cancer
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Blood

Notable recent papers include:

  • "TRUCKS, the fourth-generation CAR T cells: Current developments and clinical translation" (2020), Advances in Cell and Gene Therapy
  • "Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignancies" (2022), Blood
  • "Design and Characterization of an "All-in-One" Lentiviral Vector System Combining Constitutive Anti-GD2 CAR Expression and Inducible Cytokines" (2020), Cancers
  • "Trastuzumab derived HER2-specific CARs for the treatment of trastuzumab-resistant breast cancer: CAR T cells penetrate and eradicate tumors that are not accessible to antibodies" (2020), Cancer Letters
  • "IL7-IL12 Engineered Mesenchymal Stem Cells (MSCs) Improve A CAR T Cell Attack Against Colorectal Cancer Cells" (2020), Cells

Best Publications

  • TRUCKs: the fourth generation of CARs.

    Markus Chmielewski;Hinrich Abken

  • IL-12 release by engineered T cells expressing chimeric antigen receptors can effectively Muster an antigen-independent macrophage response on tumor cells that have shut down tumor antigen expression.

    Markus Chmielewski;Caroline Kopecky;Andreas A. Hombach;Hinrich Abken

  • CAR T Cells Releasing IL-18 Convert to T-Bethigh FoxO1low Effectors that Exhibit Augmented Activity against Advanced Solid Tumors

    Markus Chmielewski;Hinrich Abken

  • Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma.

    Markus Chmielewski;Andreas A. Hombach;Hinrich Abken

  • Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule.

    Andreas Hombach;Anja Wieczarkowiecz;Thomas Marquardt;Claudia Heuser

  • T Cell Activation by Antibody-Like Immunoreceptors: Increase in Affinity of the Single-Chain Fragment Domain above Threshold Does Not Increase T Cell Activation against Antigen-Positive Target Cells but Decreases Selectivity

    Markus Chmielewski;Andreas Hombach;Claudia Heuser;Gregory P. Adams

  • Adoptive immunotherapy with genetically engineered T cells: modification of the IgG1 Fc 'spacer' domain in the extracellular moiety of chimeric antigen receptors avoids 'off-target' activation and unintended initiation of an innate immune response.

    A Hombach;A A Hombach;H Abken

  • OX40 costimulation by a chimeric antigen receptor abrogates CD28 and IL-2 induced IL-10 secretion by redirected CD4(+) T cells.

    Andreas A. Hombach;Johannes Heiders;Marcel Foppe;Markus Chmielewski

  • Epstein Barr virus–specific cytotoxic T lymphocytes expressing the anti-CD30ζ artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease

    Barbara Savoldo;Cliona M. Rooney;Cliona M. Rooney;Antonio Di Stasi;Hinrich Abken

  • T Cells Expressing a Chimeric Antigen Receptor That Binds Hepatitis B Virus Envelope Proteins Control Virus Replication in Mice

    Karin Krebs;Nina Böttinger;Li–Rung Huang;Markus Chmielewski

  • Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas

    Anna Kruschinski;Andreas Moosmann;Isabel Poschke;Håkan Norell

  • CAR-T cells and solid tumors: tuning T cells to challenge an inveterate foe.

    David E. Gilham;Reno Debets;Martin Pule;Robert E. Hawkins

  • Coexpressed Catalase Protects Chimeric Antigen Receptor–Redirected T Cells as well as Bystander Cells from Oxidative Stress–Induced Loss of Antitumor Activity

    Maarten A. Ligtenberg;Dimitrios Mougiakakos;Madhura Mukhopadhyay;Kristina Witt

  • The Analysis of Tyrosinase-Specific mRNA in Blood Samples of Melanoma Patients by RT-PCR Is Not a Useful Test for Metastic Tumor Progression

    Uwe Reinhold;Hans-Christian Lüdtke-Handjery;Hans-Christian Lüdtke-Handjery;Sylvia Schnautz;Hans-Wilhelm Kreysel

  • Antigen-Specific T-Cell Activation Independently of the MHC: Chimeric Antigen Receptor-Redirected T Cells.

    Markus Chmielewski;Andreas A. Hombach;Hinrich Abken

  • TRUCKS, the fourth‐generation CAR T cells: Current developments and clinical translation

    Unknown

  • Costimulation by chimeric antigen receptors revisited the T cell antitumor response benefits from combined CD28-OX40 signalling.

    Andreas A. Hombach;Hinrich Abken

  • T cells that target carcinoembryonic antigen eradicate orthotopic pancreatic carcinomas without inducing autoimmune colitis in mice.

    Markus Chmielewski;Olga Hahn;Gunter Rappl;Michael Nowak

  • T Cells Redirected Against Hepatitis B Virus Surface Proteins Eliminate Infected Hepatocytes

    Felix Bohne;Markus Chmielewski;Gregor Ebert;Katja Wiegmann

  • T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.

    Andreas Hombach;Dagmar Sent;Claudia Schneider;Claudia Heuser

  • Eradication of melanomas by targeted elimination of a minor subset of tumor cells

    Patrick Schmidt;Caroline Kopecky;Andreas Hombach;Paola Zigrino

Frequent Co-Authors

Andreas Hombach
Andreas Hombach University of Cologne
Volker Diehl
Volker Diehl University of Cologne
Michael Hallek
Michael Hallek University of Cologne
Ulrike Protzer
Ulrike Protzer Technical University of Munich
Barbara Seliger
Barbara Seliger Martin Luther University Halle-Wittenberg
Soldano Ferrone
Soldano Ferrone Harvard University
Wolfgang Uckert
Wolfgang Uckert Max Delbrück Center for Molecular Medicine
Robert E. Hawkins
Robert E. Hawkins University of Manchester
Gerold Schuler
Gerold Schuler University of Erlangen-Nuremberg
Martin Krönke
Martin Krönke University of Cologne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their expertise alongside immunology, nursing-focused degrees offer valuable opportunities. Many professionals pursue a doctor of nursing practice salary that reflects advanced clinical and leadership roles across the USA. Understanding salary variations by state can help in making informed career decisions.

Transitioning within nursing specialties is also common. Programs like the fnp to acute care np bridge program allow family nurse practitioners (FNPs) to specialize further, expanding career options in acute care settings. This pathway is ideal for those seeking to enhance their clinical scope.

For faster completion, many students explore the accelerated fnp program, offering expedited routes to becoming a family nurse practitioner. These online programs are designed to balance rigorous training with flexibility.

Non-nurses eyeing entry into healthcare careers can benefit from 12-month accelerated nursing programs online for non nurses. These programs enable rapid entry into nursing through comprehensive, online curricula tailored for career changers.

Best Scientists Citing Hinrich Abken

Trending Scientists

Recently Published Articles